ClinicalTrials.Veeva

Menu

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Bausch + Lomb logo

Bausch + Lomb

Status

Completed

Conditions

Contact Lens Wear

Treatments

Device: OPTI-FREE
Device: BL-300-PFM04

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this study is to evaluate the safety and effectiveness of lubricating and rewetting drop (Test) compared to OPTI-FREE® Replenish® Rewetting Drops (Control) when used by habitual contact lens wearers to bilaterally lubricate and rewet soft (hydrophilic) contact lenses including silicone hydrogel contact lenses and gas permeable (silicone acrylate and fluoro silicone acrylate) contact lenses.

Enrollment

369 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects must be of legal age (at least 18) on the date the Informed Consent Form (ICF) is signed and have the capacity to provide voluntary informed consent
  • Subjects must be habitual wearers of included contact lenses.
  • Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
  • Subjects must agree to wear their lenses on a daily wear basis for approximately 1 month.

Exclusion criteria

• Subjects participating in any drug or device clinical investigation within two weeks prior to entry into this study and/or during the period of study participation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

369 participants in 2 patient groups

BL-300-PFM04
Experimental group
Treatment:
Device: BL-300-PFM04
Lubricating and rewetting drops
Active Comparator group
Treatment:
Device: OPTI-FREE

Trial documents
1

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems